Boosting immunity to small tumor-associated carbohydrates with bacteriophage Qβ capsids

ACS Chemical Biology

Volumn 8, Issue 6, 2013, Pages 1253-1262

  Yin, Zhaojun ^a   Comellas Aragones, Marta ^b   Chowdhury, Sudipa ^c   Bentley, Philip ^a   Kaczanowska, Katarzyna ^b   Benmohamed, Lbachir ^d   Gildersleeve, Jeffrey C ^c   Finn, M G ^b   Huang, Xuefei ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CARBOHYDRATE ANTIGEN; EPITOPE; GLYCAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; TN ANTIGEN; TUMOR ASSOCIATED CARBOHYDRATE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; CYCLOADDITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; LEUKEMIA CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS CAPSID;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BACTERIOPHAGES; CANCER VACCINES; CAPSID; FEMALE; HUMANS; IMMUNITY; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; MODELS, MOLECULAR; NEOPLASMS;

ENTEROBACTERIOPHAGE QBETA; MIRIDAE;

EID: 84879771257     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb400060x     Document Type: Article

References (57)

1. Finn, O. J. (2003) Cancer vaccines: Between the idea and the reality Nat. Rev. Immunol. 3, 630-641
2. Heimburg-Molinaro, J., Lum, M., Vijay, G., Jain, M., Almogren, A., and Rittenhouse-Olson, K. (2011) Cancer vaccines and carbohydrate epitopes Vaccine 29, 8802-8826
3. Mond, J. J., Lees, A., and Snapper, C. M. (1995) T Cell-independent antigens type 2 Annu. Rev. Immunol. 13, 655-692
4. Goldsby, R. A., Kindt, T. J., and Osborne, B. A. (2000) Kuby Immunology, pp 461-464, Freeman, New York.
5. Yin, Z. and Huang, X. (2012) Recent development in carbohydrate based anticancer vaccines J. Carbohydr. Chem. 31, 143-186 and references cited therein
6. Lin, C.-C. and Ye, X.-S. (2012) Carbohydrate-based cancer vaccines: target cancer with sugar bullets Glycoconjugate J. 29, 259-271
7. Guo, Z. W. and Wang, Q. L. (2009) Recent development in carbohydrate-based cancer vaccines Curr. Opin. Chem. Biol. 13, 608-617
8. Hoffmann-Röder, A. and Johannes, M. (2011) Synthesis of a MUC1-glycopeptide-BSA conjugate vaccine bearing the 3′-deoxy-3′- fluoro-Thomsen-Friedenreich antigen Chem. Commun. 47, 9903-9905 and references cited therein
9. Yang, F., Zheng, X.-J., Huo, C.-X., Wang, Y., Zhang, Y., and Ye, X.-S. (2011) Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen ACS Chem. Biol. 6, 252-259
10. Kuberan, B., Sikkander, S. A., Tomiyama, H., and Linhardt, R. J. (2003) Synthesis of a C-glycoside analogue of sTn: an HIV- and tumor-associated antigen Angew. Chem., Int. Ed. 42, 2073-2075
11. Chea, E. K., Fernández-Tejada, A., Damani, P., Adams, M. M., Gardner, J. R., Livingston, P. O., Ragupathi, G., and Gin, D. Y. (2012) Synthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probes J. Am. Chem. Soc. 134, 13448-13457
12. Chen, W., Gu, L., Zhang, W., Motari, E., Cai, L., Styslinger, T. J., and Wang, P. G. (2011) l -rhamnose antigen: a promising alternative to alpha-gal for cancer immunotherapies ACS Chem. Biol. 6, 185-191 and references cited therein
13. Sarkar, S., Lombardo, S. A., Herner, D. N., Talan, R. S., Wall, K. A., and Sucheck, S. J. (2010) Synthesis of a single-molecule l -rhamnose-containing three-component vaccine and evaluation of antigenicity in the presence of anti- l -rhamnose antibodies J. Am. Chem. Soc. 132, 17236-17246
14. Heegaard, P. M. H., Boas, U., and Sorensen, N. S. (2010) Dendrimers for vaccine and immunostimulatory uses. A review Bioconjugate Chem. 21, 405-418
15. Zhu, J. L., Warren, J. D., and Danishefsky, S. J. (2009) Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience Expert Rev. Vaccines 8, 1399-1413
16. De Silva, R. A., Wang, Q., Chidley, T., Appulage, D. K., and Andreana, P. R. (2009) Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates J. Am. Chem. Soc. 131, 9622-9623
17. Brinas, R. P., Sundgren, A., Sahoo, P., Morey, S., Rittenhouse-Olson, K., Wilding, G. E., Deng, W., and Barchi, J. J. (2012) Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines Bioconjugate Chem. 23, 1513-1523
18. Ojeda, R., de Paz, J. L., Barrientos, A. G., Martin-Lomas, M., and Penades, S. (2007) Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines Carbohydr. Res. 342, 448-459
19. Estevez, F. C., A., Solorzano, L., Valiente, O., Mesa, C., Barroso, O., Sierra, G. V., and Fernandez, L. E. (1999) Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP) Vaccine 18, 190-197
20. Lo-Man, R., Vichier-Guerre, S., Perraut, R., Deriaud, E., Huteau, V., BenMohamed, L., Diop, O. M., Livingston, P. O., Bay, S., and Leclerc, C. (2004) A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates Cancer Res. 64, 4987-4994
21. Kaiser, A., Gaidzik, N., Westerlind, U., Kowalczyk, D., Hobel, A., Schmitt, E., and Kunz, H. (2009) A synthetic vaccine consisting of a tumor-associated sialyl-Tn MUC1 tandem-repeat glycopeptide and tetanus toxoid: induction of a strong and highly selective immune response Angew. Chem., Int. Ed. 48, 7551-7555
22. Lakshminarayanan, V., Thompson, P., Wolfert, M. A., Buskas, T., Bradley, J. M., Pathangey, L. B., Madsen, C. S., Cohen, P. A., Gendler, S. J., and Boons, G.-J. (2012) Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine Proc. Natl. Acad. Sci. U. S. A. 109, 261-266
23. Bettahi, I., Dasgupta, G., Renaudet, O., Chentoufi, A. A., Zhang, X., Carpenter, D., Yoon, S., Dumy, P., and BenMohamed, L. (2009) Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes Cancer Immunol. Immunother. 58, 187-200
24. Yin, Z., Nguyen, H. G., Chowdhury, S., Bentley, P., Bruckman, M. A., Miermont, A., Gildersleeve, J. C., Wang, Q., and Huang, X. (2012) Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens Bioconjugate Chem. 23, 1694-1703
25. Miermont, A., Barnhill, H., Strable, E., Lu, X. W., Wall, K. A., Wang, Q., Finn, M. G., and Huang, X. (2008) Cowpea mosaic virus capsid: A promising carrier for the development of carbohydrate based antitumor vaccines Chem.-Eur. J. 14, 4939-4947
26. Kaltgrad, E., Sen Gupta, S., Punna, S., Huang, C. Y., Chang, A., Wong, C. H., Finn, M. G., and Blixt, O. (2007) Anti-carbohydrate antibodies elicited by polyvalent display on a viral scaffold ChemBiochem 8, 1455-1462
27. Roldão, A., Mellado, M. C., Castilho, L. R., Carrondo, M. J., and Alves, P. M. (2010) Virus-like particles in vaccine development Expert Rev. Vaccines 9, 1149-1176
28. Bachmann, M. F. and Jennings, G. T. (2010) Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns Nat. Rev. Immunol. 10, 787-796
29. Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., and Hubbell, J. A. (2007) Exploiting lymphatic transport and complement activation in nanoparticle vaccines Nat. Biotechnol. 25, 1159-1164
30. Bachmann, M. F., Rohrer, U. H., Kundig, T. M., Burki, K., Hengartner, H., and Zinkernagel, R. M. (1993) The influence of antigen organization on B cell responsiveness Science 262, 1448-1451
31. Bachmann, M. F. and Zinkernagel, R. M. (1997) Neutralizing antiviral B cell responses Annu. Rev. Immunol. 15, 235-270
32. Kumar, H., Kawai, T., and Akira, S. (2009) Toll-like receptors and innate immunity Biochem. Biophys. Res. Commun. 388, 621-625
33. Di John, D., Wasserman, S. S., Torres, J. R., Cortesia, M. J., Murillo, J., Losonsky, G. A., Herrington, D. A., Sturcher, D., and Levine, M. M. (1989) Effect of priming with carrier on response to conjugate vaccine Lancet 334, 1415-1418
34. Herzenberg, L. A. and Tokuhisa, T. (1982) Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses J. Exp. Med. 155, 1730-1740
35. Golmohammadi, R., Fridborg, K., Bundule, M., Valegard, K., and Liljas, L. (1996) The crystal structure of bacteriophage Qβ at 3.5Å resolution Structure 4, 543-554
36. Cazet, A., Julien, S., Bobowski, M., Burchell, J., and Delannoy, P. (2010) Tumour-associated carbohydrate antigens in breast cancer Breast Cancer Res. 12, 204
37. Li, Q., Anver, M. R., Butcher, D. O., and Gildersleeve, J. C. (2009) Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines Mol. Cancer Ther. 8, 971-979
38. Kawaguchi, T., Takazawa, H., Imai, S., Morimoto, J., Watanabe, T., Kanno, M., and Igarashi, S. (2006) Expression of Vicia villosa agglutinin (VVA)-binding glycoprotein in primary breast cancer cells in relation to lymphatic metastasis: is atypical MUC1 bearing Tn antigen a receptor of VVA? Breast Cancer Res. Treat. 98, 31-43
39. Buskas, T., Ingale, S., and Boons, G.-J. (2005) Towards a fully synthetic carbohydrate-based anticancer vaccine: Synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated Tn antigen Angew. Chem., Int. Ed. 44, 5985-5988
40. Kagan, E., Ragupathi, G., Yi, S. S., Reis, C. A., Gildersleeve, J., Kahne, D., Clausen, H., Danishefsky, S. J., and Livingston, P. O. (2005) Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn Cancer Immunol. Immunother. 54, 424-430
41. Hong, V., Presolski, S. I., Ma, C., and Finn, M. G. (2009) Analysis and optimization of copper-catalyzed azide-alkyne cycloaddition for bioconjugation Angew. Chem., Int. Ed. Engl. 48, 9879-9883
42. Astronomo, R. D., Kaltgrad, E., Udit, A. K., Wang, S. K., Doores, K. J., Huang, C. Y., Pantophlet, R., Paulson, J. C., Wong, C. H., Finn, M. G., and Burton, D. R. (2010) Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds Chem. Biol. 17, 357-370 and references cited therein
43. Prasuhn, D. E., Jr., Singh, P., Strable, E., Brown, S., Manchester, M., and Finn, M. G. (2008) Plasma clearance of bacteriophage Qβ particles as a function of surface charge J. Am. Chem. Soc. 130, 1328-1334
44. Lau, J. L., Baksh, M. M., Fiedler, J. D., Brown, S. D., Kussrow, A., Bornhop, D. J., Ordoukhanian, P., and Finn, M. G. (2011) Evolution and protein packaging of small molecule RNA aptamers ACS Nano 5, 7722-7729
45. Ni, J., Song, H., Wang, Y., Stamatos, N. M., and Wang, L.-X. (2006) Toward a carbohydrate-based HIV-1 vaccine: Synthesis and immunological studies of oligomannose-containing glycoconjugates Bioconjugate Chem. 17, 493-500
46. Blixt, O., Lavrova, O. I., Mazurov, D. V., Cló, E., Kračun, S. K., Bovin, N. V., and Filatov, A. V. (2012) Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells Glycobiology 22, 529-542
47. Finkelman, F. D., Holmes, J., Katona, I. M., Urban, J. F., Jr., Beckman, M. P., Park, L. S., Schooley, K. A., Coffman, R. L., Mosmann, T. R., and Paul, W. E. (1990) Lymphokine control of in vivo immunoglobulin isotype selection Annu. Rev. Immunol. 8, 303-333
48. Snapper, C. M., McIntyre, T. M., Mandler, R., Pecanha, L. M. T., Finkelman, F. D., Lees, A., and Mond, J. J. (1992) Induction of IgG3 secretion by interferon γ: a model for for T cell-independent class switching in response to T cell-independent type 2 antigens J. Exp. Med. 175, 1367-1371
49. Wang, Q., Zhou, Z., Tang, S., and Guo, Z. (2012) Carbohydrate- monophosphoryl lipid A conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouse ACS Chem. Biol. 235-240
50. Bay, S., Fort, S., Birikaki, L., Ganneau, C., Samain, E., Coic, Y. M., Bonhomme, F., Deriaud, E., Leclerc, C., and Lo-Man, R. (2009) Induction of a melanoma-specific antibody response by a monovalent, but not a divalent, synthetic GM2 neoglycopeptide ChemMedChem 4, 582-587
51. Lipinski, T., Luu, T., Kitov, P. I., Szpacenko, A., and Bundle, D. R. (2011) A structurally diversified linker enhances the immune response to a small carbohydrate hapten Glycoconjugate J. 28, 149-164
52. Costantino, P., Rappuoli, R., and Berti, F. (2011) The design of semi-synthetic and synthetic glycoconjugate vaccines Expert Opin. Drug Discovery 6, 1045-1066 and references cited therein
53. Jegerlehner, A., Storni, T., Lipowsky, G., Schmid, M., Pumpens, P., and Bachmann, M. F. (2002) Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation Eur. J. Immunol. 32, 3305-3314
54. Chackerian, B., Lenz, P., Lowy, D. R., and Schiller, J. T. (2002) Determinants of autoantibody induction by conjugated Papillomavirus virus-like particles J. Immunol. 169, 6120-6126
55. Dagan, R., Eskola, J., Leclerc, C., and Leroy, O. (1998) Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants Infect. Immun. 66, 2093-2098
56. Oyelaran, O. and Gildersleeve, J. C. (2009) Glycan arrays: recent advances and future challenges Curr. Opin. Chem. Biol. 13, 406-413
57. Nakada, H., Inoue, M., Tanaka, N., Numata, Y., Kitagawa, H., Fukui, S., and Yamashina, I. (1991) Expression of the Tn antigen on T-lymphoid cell line Jurkat Biochem. Biophys. Res. Commun. 179, 762-767